|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the CVS 8-K filed Jan 19, 2007. Code
),
and (ii) the material federal income tax consequences of the Merger to holders
of Caremark common stock and CVS common stock will be as described in the
Registration Statement under the caption Material Federal Income Tax
Consequences of the Special Cash Dividend and the Merger, subject to
the qualifications and limitations set forth therein.
Our opinion is based upon the Code, the Treasury Regulations thereunder, and administrative and judicial interpretations thereof, all as in effect on the date hereof. No assurance can be given that any of the foregoing authorities will not be modified, revoked, supplemented or overruled, with possibly retroactive effect. Our opinion is limited to the matters expressly stated herein and no opinion is implied or may be inferred beyond the matters expressly stated herein. Our opinion is rendered only as of the date hereof. We assume no obligation to advise you of changes of law that occur after the date hereof, or of any facts, circumstances, events or developments that hereafter may be brought to our attention and that may alter, affect or modify the opinion set forth herein. We hereby consent to the filing of this opinion with the SEC as an exhibit to the Registration Statement. We also consent to the references to our name under the headings Material Federal Income Tax Consequences of the Special Cash Dividend and the Merger in the Joint Proxy Statement. In giving this consent, we do not thereby concede that we are within the category of persons whose consent is required under Section 7 of the Act or the General Rules and Regulations of the SEC thereunder.
| |||||||||||||||||||